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Introduction
The cAMP response element (CRE) modulator (CREM)a
binds to promoters of genes with CREs and regulates
transcription via a chromatin-dependent mechanism.
CREMa is important for the T cell pathophysiology of
SLE by suppression of IL-2 and CD3ζ but enhancement of
IL-17 transcription. Juvenile idiopathic arthritis (JIA) is an
autoimmune disease of unknown origin. Th17 cells have a
pathogenic role in arthritis and are not controlled by local
FoxP3+ regulatory T cells (Tregs). Pathogenic T cells in
the inflamed joints of JIA patients have enhanced expres-
sion of IL-17, IFN-g and CD161. CD161+ CD4+ cells also
contain FoxP3+ cells that produce proinflammatory cyto-
kines. A higher frequency of CD161 Tregs appears to
associate with more severe disease in JIA, a fact which
might contribute to the failure by Treg to suppress
ongoing inflammation.
Objectives
The aim of this study was to evaluate the role of CREM-
expressing T cells in juvenile idiopathic arthritis.
Methods
T cells and peripheral blood mononuclear cells (PBMCs)
from healthy donors and JIA patients as well as synovial
fluid mononuclear cells (SFMCs) from JIA patients were
stimulated in vitro with anti-CD3/CD28 antibodies.
PBMCS from healthy donors were incubated in the
presence of synovial fluid from JIA patients. CREMa was
knocked down in PBMCs and SFMCs by transfection with
CREM siRNA.Flow cytometry was used to measure
CREM protein, CD161, Helios and FoxP3 expression as
well as secretion of cytokines. RNA was quantified by
quantitative Real-time PCR.
Results
We observed enhanced expression of CREM in synovial
fluid T cells from JIA patients. Enhanced expression of
CREM was also induced after ex vivo culture of PBMCs
from healthy donors with synovial fluid from JIA patients.
We furthermore found enhanced expression of CREM in
CD4+CD161+ and in CD4+FoxP3+CD161+ cells, which are
known producers of inflammatory cytokines, compared to
CD4+CD161- and CD4+FoxP3+CD161- cells. Vice versa
Helios+FoxP3+ cells, which are supposed to be stable
Tregs and do not express inflammatory cytokines, showed
lower levels of CREM expression. Incubation with synovial
fluid induced the expression of IFN-g, IL-17 and FoxP3 in
T cells, which could be reserved by transfection of CREM
siRNA. Within the FoxP3+ population, CREMsiRNA
reduced CD161+FoxP3+ cells but hardly affected Helios
+FoxP3+ cells. We next asked what drives enhanced
expression of CREM in synovial fluid stimulated T cells
and if pharmacologic inhibition of these factors might
reduce occurrence of inflammatory Tregs and effetor
T cells. Interestingly in in vitro assays both Anakinra as
well as Enbrel, which antagonize IL-1 respectively TNF-a
signaling downregulated expression of inflammatory cyto-
kines in T cells and both downregulated CREM expression
as well. We then aimed to directly block CREM activating
by inhibiting Calcium/calmodulin-dependent protein
kinase type IV (CaMKIV).We have shown before that SLE
serum IgG activates CaMKIV and identified CaMKIV as
being responsible for the increased expression of CREM in
SLE T cells. Inhibition of CaMKIV in PBMCS markedly
downregulated CREM expression and reduced numbers of
IL-17 and IFN-g producing T cells.
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Conclusion
We thus suggest that the overexpression of CREMa in
T cells contributes to T cell pathophysiology in JIA by
regulating percentages of inflammatory CD4+ IL-17+
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